FDA — authorised 28 October 2010
- Marketing authorisation holder: SUNOVION PHARMS INC
- Status: approved
FDA authorised Latuda on 28 October 2010
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 October 2010.
SUNOVION PHARMS INC holds the US marketing authorisation.